CVDのリスクが高い人の日内血圧パターン
心血管疾患のリスクが高い人の日内血圧と動脈硬化パターン
In health, blood pressure (BP) falls at night by >10% compared with day-time values. This natural dipping pattern is important as without it there is an increased risk of cardiovascular disease (CVD). Recent evidence suggests that chronotherapy (taking anti-hypertensive medication at bedtime instead of in the morning) may enhance nocturnal BP dipping and reduce the risk of CVD events. There is therefore an urgent need to characterise diurnal BP patterns in patients who may be at risk of reduced nocturnal dipping in order to maximise protective therapy in all those who would benefit. Similarly, it has previously been demonstrated that increased arterial stiffness is associated with increased CVD risk, however little is known about whether loss of diurnal variations in arterial stiffness confer addition risk. Kidney disease is independently associated with increased CVD events, but the exact makeup of this risk is not clear. Within this heterogenous cohort several very distinct groups exist including those with acute kidney injury (AKI), chronic kidney disease (CKD), inflammatory conditions like small vessel vasculitis (SVV), and those who have either donated or received a kidney transplant. Diurnal BP and arterial stiffness patterns within these patient groups are not well characterised. The investigators will recruit patients at increased risk of CVD from the Royal Infirmary of Edinburgh Renal and Vasculitis Clinics. Participants will undergo 24-hour ambulatory BP and arterial stiffness measurement in conjunction with day- and night-time blood and urine sampling on two separate occasions. This study aims to characterise diurnal patterns of BP and arterial stiffness in patients at increased risk of CVD and compare findings with healthy controls. In doing so, the investigators aim to allow more targeted CVD risk reduction strategies and improve long-term patient outcomes.
調査の概要
状態
研究の種類
入学 (推定)
連絡先と場所
研究連絡先
- 名前:Neeraj Dhaun, MBChB PhD
- 電話番号:07968810899
- メール:bean.dhaun@ed.ac.uk
研究場所
-
-
-
Edinburgh、イギリス、EH164SA
- 募集
- Royal Infirmary of Edinburgh
-
コンタクト:
- Neeraj Dhaun, MBChB PhD
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
サンプリング方法
調査対象母集団
As above
説明
Inclusion Criteria:
-
Patients will be eligible to take part in the study if they attend NHS Lothian inpatient or outpatient services and can be classified as being at increased risk of CVD. This will include, but is not limited to, the following subgroups:
- CKD as defined by the Kidney Disease Outcome Quality Initiative (K/DOQI) classification
- AKI as defined by the Kidney Disease Improving Global Outcomes (KDIGO) classification
- Small vessel vasculitis
- Kidney transplant recipient
- Kidney donor We will also recruit a healthy control group from the community.
Exclusion Criteria:
- Age <18 years and >90 years
- Lack of ability to provide informed consent
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 観測モデル:COHORT
- 時間の展望:PROSPECTIVE
コホートと介入
グループ/コホート |
介入・治療 |
|---|---|
|
Health
Healthy individuals with no known medical condition and taking no regular medication |
Assessment of 24 hour blood pressure and arterial stiffness using Mobil-o-graph device |
|
Acute kidney injury
Individuals with acute kidney injury as defined by KDIGO criteria |
Assessment of 24 hour blood pressure and arterial stiffness using Mobil-o-graph device |
|
Chronic kidney disease
Individuals with chronic kidney disease as defined by KDIGO criteria |
Assessment of 24 hour blood pressure and arterial stiffness using Mobil-o-graph device |
|
Small vessel vasculitis
Individuals with active small vessel vasculitis an diagnosed by a specialist physician |
Assessment of 24 hour blood pressure and arterial stiffness using Mobil-o-graph device |
|
Kidney transplant recipient
Individuals who have received a kidney transplant |
Assessment of 24 hour blood pressure and arterial stiffness using Mobil-o-graph device |
|
Kidney donor
Individuals who have donated a kidney for transplantation |
Assessment of 24 hour blood pressure and arterial stiffness using Mobil-o-graph device |
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Nocturnal BP dip
時間枠:24 hours
|
Percentage change between mean day-time and mean night-time blood pressure |
24 hours
|
|
Nocturnal arterial stiffness dip
時間枠:24 hours
|
Percentage change between mean day-time and mean night-time arterial stiffness |
24 hours
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Change in urine ET-1 concentration when measured in the morning (06:00 - 12:00) and in the evening (18:00-00:00)
時間枠:Morning (06:00-12:00) and evening (18:00-00:00)
|
Measurement of urine ET-1 concentration in the morning (06:00 - 12:00) and in the evening (18:00-00:00) |
Morning (06:00-12:00) and evening (18:00-00:00)
|
|
Change in plasma ET-1 concentration when measured in the morning (06:00 - 12:00) and in the evening (18:00-00:00)
時間枠:Morning (06:00-12:00) and evening (18:00-00:00)
|
Measurement of plasma ET-1 concentration in the morning (06:00 - 12:00) and in the evening (18:00-00:00) |
Morning (06:00-12:00) and evening (18:00-00:00)
|
協力者と研究者
スポンサー
捜査官
- 主任研究者:Neeraj Dhaun, MBChB PhD、University of Edinburgh
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
追加の関連 MeSH 用語
その他の研究ID番号
- AC19178
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
There is no plan to share IPD
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。